Phase II trial of nintedanib in patients with bevacizumab-resistant recurrent epithelial ovarian, tubal, and peritoneal cancer - Concepedia

Concepedia

Publication | Closed Access

Phase II trial of nintedanib in patients with bevacizumab-resistant recurrent epithelial ovarian, tubal, and peritoneal cancer

29

Citations

24

References

2019

Year

Angeles Alvarez Secord, Michael McCollum, Brittany A. Davidson, Gloria Broadwater, Robert C. Squatrito, Laura J. Havrilesky, Anne C. Gabel, Mark D. Starr, John C. Brady, Andrew B. Nixon,

Gynecologic Oncology

Phase Ii TrialPeritoneal CancerMedicineMetronomic TherapyGynecologyCancer TreatmentBevacizumab-resistant RecurrentOncologyRadiation OncologyGynecology OncologyOvarian Cancer

References

	Year	Citations

Page 1

Page 1